Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss Notified -
Countdown For A Cure Awards $350,000 Grant to Minovia Therapeutics to Advance Groundbreaking Mitochondrial Biomarker Research Notified -
VCI Global Partners with Reveillon Group to Launch Global RWA Lounge Network and Creator Monetization Platform Notified -
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds Notified -
Wood Mackenzie launches Nodal Price Forecast [img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=01b9de8c-466d-4f5d-be57-0216053ef4b6&size=3[/img]Notified -
Acronis and Intel Partner to Deliver Efficient, AI-Driven Threat Detection for Endpoint Devices Notified -
Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers Notified -